NCT02203487View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Increasing Repeated Doses of BIIF 1149 BS in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

June 30, 2000

Conditions
Healthy
Interventions
DRUG

BIIF 1149 BS - single rising dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY